Cell and Gene Logistics

CRYOPDP: Scientist Conducting DNA Analysis in Cell and Gene Logistics Laboratory

Within our CRYOPDP’s global teams, there is active involvement in Advanced Therapy Medicinal Products (ATMPs), including cell and gene therapy programmes and Cell and Gene Logistics.

This work supports client requirements across time and temperature-sensitive supply chains, with a focus on control, traceability, and compliant handling. ATMPs, including cell and gene therapies, are changing treatment approaches in areas such as cancer and rare diseases, where shipment conditions and timing can directly affect product integrity.

Patient Receiving Treatment

Precision in ATMP Transport:

ATMP logistics, including cell and gene therapy logistics, require strict control during transport. Patient-specific therapies carry a higher risk because timing, temperature range, chain of custody, and documentation must remain consistent from collection through delivery. 

Patient-Centric Approach:

CRYOPDP supports a patient-centric supply chain

through compliant handling, traceability, and defined escalation when conditions change. Work with partners focuses on regulatory alignment, shipment security, and reducing avoidable impact from delays, deviations, and rework.

CRYOPDP Direct-to-Patient Delivery: Patient with Family

Premium Temperature-Controlled Logistics Solutions:

Temperature-controlled logistics requires defined controls to reduce risk and maintain shipment visibility. Services cover shipment planning and execution, including packaging selection, route planning, documentation, and import and export support. Tracking provides location and status updates during transport. Solutions are tailored to the product profile, temperature range, route complexity, and compliance requirements.

Control Tower Excellence:

CRYOPDP manages cell and gene therapy shipments with centralised monitoring and reporting. The Control Tower team coordinates shipment status updates, escalation when conditions change, and consistent process control across stakeholders.

Striking the Right Balance:

Patient-focused ATMP leave little margin for error.

Security, regulatory compliance, and cost control must be managed without compromising temperature requirements or chain of custody.

By keeping these controls consistent, logistics can contribute to global health by helping patient therapies reach the right place at the right time, including through direct-to-patient delivery models.

A 24/7 service model keeps decision paths clear when conditions change.

CRYOPDP: Laboratory for Scientific Research

CRYOPDP offers:

  • Packaging for all temperature ranges: Packaging selection matched to the required range to protect product integrity.
  • Control Tower: Central oversight for monitoring, reporting, and escalation.

  • Temperature monitoring: Ongoing temperature monitoring during transport to keep shipments within range.

  • Project management: Dedicated coordination for shipment planning, documentation, and operational follow-up.

  • GDP-aligned processes and contingency planning: Documented processes aligned to GDP expectations, with defined contingency steps for disruptions.

  • 24/7 support: Round-the-clock availability for shipment updates and issue resolution.

  • Consultancy: Support to review routes, risks, packaging, and operating processes for specific programmes.